COMMUNIQUÉS West-GlobeNewswire

Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference

05/03/2018 - 22:01

WEST LAFAYETTE, March 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment , today announced that the company’s [...]

Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors

05/03/2018 - 22:01

Spring Bank strengthens Board of Directors with the addition of a prominent biopharma R&D veteran HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical- [...]

Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe

05/03/2018 - 22:01

BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Hans van Eenennaam, Ph.D. has been promoted to executive vice president antibody research and site head of [...]

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2018

05/03/2018 - 22:01

RANCHO CUCAMONGA, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the Company will release results for its fourth quarter of 2017 ended December 31, 2017, after [...]

Maple Leaf Provides Update on its Telkwa, British Columbia Facility

05/03/2018 - 22:01

CALGARY, Alberta, March 05, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSXV:MGW) (OTCQB:MGWFF) is pleased to announce it has received a progress report from the Company’s [...]

Cytokinetics to Present at March Investor Conferences

05/03/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate [...]

Galectin Therapeutics Announces Record Date and Annual Stockholders Meeting Date for 2018

05/03/2018 - 22:00

NORCROSS, Ga., March 05, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced March 26, 2018 is the record date for [...]

OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call

05/03/2018 - 22:00

GAITHERSBURG, Md., March 05, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that the Company will report its fourth quarter and fiscal year 2017 financial results after close of market on Thursday [...]

Kevin J. Dallas Joins Align Technology Board of Directors

05/03/2018 - 22:00

SAN JOSE, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) announced today that it has appointed Kevin J. Dallas to its board of directors. Mr. Dallas is Corporate Vice President, [...]

Obalon Announces Fourth Quarter and Full Year 2017 Financial Results

05/03/2018 - 21:01

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]

New Opportunity Navigator™ Predictive Analytics Solution Refined Through Vital Images® and Fairview Collaboration

05/03/2018 - 20:49

Solution provides next-generation analytics with predictive capabilities MINNETONKA, Minn., March 05, 2018 (GLOBE NEWSWIRE) -- Vital Images announced today it refined its latest innovation, Vitrea ® Intelligence [...]

Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners

05/03/2018 - 19:26

BOULDER, Colo., March 05, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc., a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology, today announced that the [...]

Notification about capital shares

05/03/2018 - 18:52

Latvia, 2018-03-05 18:52 CET (GLOBE NEWSWIRE) -- AS ”Latvijas Jūras medicīnas centrs” informs it has sold 50.4% from share capital SIA “Klīnika Dzintari”. The deal is finished on 23 February, 2018. and AS ”Latvijas [...]

GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March

05/03/2018 - 18:36

LONDON and CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH ) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]

Healthwise and Mytonomy Partner to Deliver Health Education Videos

05/03/2018 - 18:18

BOISE, Idaho, March 05, 2018 (GLOBE NEWSWIRE) -- Healthwise and Mytonomy announced today that they will partner in offering patient instructions and health education videos to health care providers and their patients. [...]

Adaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018

05/03/2018 - 18:12

PHILADELPHIA and OXFORD, United Kingdom, March 05, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will announce financial results for the Fourth [...]

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2018

05/03/2018 - 18:01

Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 28 février 2018

05/03/2018 - 18:01

Nombre total de droits de vote et d'actions composant le capital social au 28 février 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]

VALNEVA : Déclaration d'actions et de droits de vote - février 2018

05/03/2018 - 18:01

VALNEVA Déclaration d'actions et de droits de vote - FEVRIER 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]